Chemosensitizing effect of podophyllotoxin acetate on topoisomerase inhibitors leads to synergistic enhancement of lung cancer cell apoptosis

Hong,Wan Gi; Cho,Jeong Hyun; Hwang,Sang-Gu; Lee,Eunah; Lee,Jaeseok; Kim,Jong-Il; Um,Hong-Duck; Park,Jong Kuk

doi:10.3892/ijo.2016.3471

Chemosensitizing effect of podophyllotoxin acetate on topoisomerase inhibitors leads to synergistic enhancement of lung cancer cell apoptosis

Authors:
- Wan Gi Hong
- Jeong Hyun Cho
- Sang-Gu Hwang
- Eunah Lee
- Jaeseok Lee
- Jong-Il Kim
- Hong-Duck Um
- Jong Kuk Park
View Affiliations

Affiliations: Department of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Nowon-Gu, Seoul, Republic of Korea, Graduate School of Biotechnology, Kyung Hee University, Yongin-si, Geonggi-do, Republic of Korea, Department of Biological Science, College of Biological Science, Konkuk University, Seoul, Republic of Korea, Department of Food and Microbial Technology, College of Natural Sciences, Seoul Women's University, Seoul, Republic of Korea
Published online on: April 1, 2016 https://doi.org/10.3892/ijo.2016.3471
Pages: 2265-2276
Copyright: © Hong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Podophyllotoxin acetate (PA) acts as a radiosensitizer against non-small cell lung cancer (NSCLC) in vitro and in vivo. In this study, we examined its potential role as a chemosensitizer in conjunction with the topoisomerase inhibitors etoposide (Eto) and camptothecin (Cpt). The effects of combinations of PA and Eto/Cpt were examined with CompuSyn software in two NSCLC cell lines, A549 and NCI-H1299. Combination index (CI) values indicated synergistic effects of PA and the topoisomerase inhibitors. The intracellular mechanism underlying synergism was further determined using propidium iodide uptake, immunoblotting and electrophoretic mobility shift assay (EMSA). Combination of PA with Eto/Cpt promoted disruption of the dynamics of actin filaments, leading to subsequent enhancement of apoptotic cell death via induction of caspase-3, -8, and -9, accompanied by increased phosphorylation of p38. Conversely, suppression of p38 phosphorylation blocked the apoptotic effect of the drug combinations. Notably, CREB-1, a transcription factor, was constitutively activated in both cell types, and synergistically inhibited upon combination treatment. Our results collectively indicate that PA functions as a chemosensitizer by enhancing apoptosis through activation of the p38/caspase axis and suppression of CREB-1.

View Figures

View References

1	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
2	Mitsudomi T, Suda K and Yatabe Y: Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol. 10:235–244. 2013. View Article : Google Scholar : PubMed/NCBI
3	Ismael GF, Rosa DD, Mano MS and Awada A: Novel cytotoxic drugs: Old challenges, new solutions. Cancer Treat Rev. 34:81–91. 2008. View Article : Google Scholar
4	Choi JY, Cho HJ, Hwang SG, Kim WJ, Kim JI, Um HD and Park JK: Podophyllotoxin acetate enhances γ-ionizing radiation-induced apoptotic cell death by stimulating the ROS/p38/caspase pathway. Biomed Pharmacother. 70:111–118. 2015. View Article : Google Scholar : PubMed/NCBI
5	Gordaliza M, García PA, del Corral JM, Castro MA and Gómez-Zurita MA: Podophyllotoxin: Distribution, sources, applications and new cytotoxic derivatives. Toxicon. 44:441–459. 2004. View Article : Google Scholar : PubMed/NCBI
6	Guerram M, Jiang Z-Z and Zhang L-Y: Podophyllotoxin, a medicinal agent of plant origin: Past, present and future. Chin J Nat Med. 10:161–169. 2012. View Article : Google Scholar
7	Wall ME, Wani MC, Cooke CE, Palmer KH, McPhail AT and Sim GA: Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor nhibitor from Camptotheca acuminata. J Am Chem Soc. 88:3888–3890. 1966. View Article : Google Scholar
8	Hsiang Y-H, Hertzberg R, Hecht S and Liu LF: Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 260:14873–14878. 1985.PubMed/NCBI
9	Gabr A, Kuin A, Aalders M, El-Gawly H and Smets LA: Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH. Cancer Res. 57:4811–4816. 1997.PubMed/NCBI
10	Venditto VJ and Simanek EE: Cancer therapies utilizing the camptothecins: A review of the in vivo literature. Mol Pharm. 7:307–349. 2010. View Article : Google Scholar : PubMed/NCBI
11	Choi JY, Hong WG, Cho JH, Kim EM, Kim J, Jung CH, Hwang SG, Um HD and Park JK: Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy. Int J Oncol. 47:1257–1265. 2015.PubMed/NCBI
12	Park JK, Jung HY, Park SH, Kang SY, Yi MR, Um HD and Hong SH: Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells. Int J Radiat Oncol Biol Phys. 70:1552–1560. 2008. View Article : Google Scholar : PubMed/NCBI
13	Park JK, Park SH, So K, Bae IH, Yoo YD and Um HD: ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int J Oncol. 36:181–192. 2010.
14	Piva R, Belardo G and Santoro MG: NF-kappaB: A stress-regulated switch for cell survival. Antioxid Redox Signal. 8:478–486. 2006. View Article : Google Scholar : PubMed/NCBI
15	Shabbits JA, Hu Y and Mayer LD: Tumor chemosensitization strategies based on apoptosis manipulations. Mol Cancer Ther. 2:805–813. 2003.PubMed/NCBI
16	Reed JC: Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol. 7:541–546. 1995. View Article : Google Scholar : PubMed/NCBI
17	LaCasse EC, Baird S, Korneluk RG and MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 17:3247–3259. 1998. View Article : Google Scholar
18	Turrini E, Ferruzzi L and Fimognari C: Natural compounds to overcome cancer chemoresistance: Toxicological and clinical issues. Expert Opin Drug Metab Toxicol. 10:1677–1690. 2014. View Article : Google Scholar : PubMed/NCBI
19	Rudolf E and Cervinka M: Topoisomerases and tubulin inhibitors: A promising combination for cancer treatment. Curr Med Chem Anticancer Agents. 3:421–429. 2003. View Article : Google Scholar : PubMed/NCBI
20	Houghton PJ, Cheshire PJ, Hallman JD II, Lutz L, Friedman HS, Danks MK and Houghton JA: Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. Cancer Chemother Pharmacol. 36:393–403. 1995. View Article : Google Scholar : PubMed/NCBI
21	Bunn PA Jr and Kelly K: New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions. Clin Cancer Res. 4:1087–1100. 1998.PubMed/NCBI
22	Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
23	Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A and Blumberg JB: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst. 100:773–783. 2008. View Article : Google Scholar : PubMed/NCBI
24	Van Laethem A, Nys K, Van Kelst S, Claerhout S, Ichijo H, Vandenheede JR, Garmyn M and Agostinis P: Apoptosis signal regulating kinase-1 connects reactive oxygen species to p38 MAPK-induced mitochondrial apoptosis in UVB-irradiated human keratinocytes. Free Radic Biol Med. 41:1361–1371. 2006. View Article : Google Scholar : PubMed/NCBI
25	Pang H, Cai L, Yang Y, Chen X, Sui G and Zhao C: Knockdown of osteopontin chemosensitizes MDA-MB-231 cells to cyclophosphamide by enhancing apoptosis through activating p38 MAPK pathway. Cancer Biother Radiopharm. 26:165–173. 2011. View Article : Google Scholar : PubMed/NCBI
26	Shin DY, Lee WS, Lu JN, Kang MH, Ryu CH, Kim GY, Kang HS, Shin SC and Choi YH: Induction of apoptosis in human colon cancer HCT-116 cells by anthocyanins through suppression of Akt and activation of p38-MAPK. Int J Oncol. 35:1499–1504. 2009.PubMed/NCBI
27	Chiu SJ, Chao JI, Lee YJ and Hsu TS: Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells. Toxicol Lett. 179:63–70. 2008. View Article : Google Scholar : PubMed/NCBI
28	Lou X, Zhou Q, Yin Y, Zhou C and Shen Y: Inhibition of the met receptor tyrosine kinase signaling enhances the chemosensitivity of glioma cell lines to CDDP through activation of p38 MAPK pathway. Mol Cancer Ther. 8:1126–1136. 2009. View Article : Google Scholar : PubMed/NCBI
29	Crans HN and Sakamoto KM: Transcription factors and translocations in lymphoid and myeloid leukemia. Leukemia. 15:313–331. 2001. View Article : Google Scholar : PubMed/NCBI
30	Pigazzi M, Ricotti E, Germano G, Faggian D, Aricò M and Basso G: cAMP response element binding protein (CREB) over-expression CREB has been described as critical for leukemia progression. Haematologica. 92:1435–1437. 2007. View Article : Google Scholar : PubMed/NCBI
31	Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A, Rao NP, Landaw EM and Sakamoto KM: The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell. 7:351–362. 2005. View Article : Google Scholar : PubMed/NCBI
32	Seo H-S, Liu DD, Bekele BN, Kim MK, Pisters K, Lippman SM, Wistuba II and Koo JS: Cyclic AMP response element-binding protein overexpression: A feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res. 68:6065–6073. 2008. View Article : Google Scholar : PubMed/NCBI
33	Shaywitz AJ and Greenberg ME: CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 68:821–861. 1999. View Article : Google Scholar
34	Mayr B and Montminy M: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2:599–609. 2001. View Article : Google Scholar : PubMed/NCBI
35	Mayr BM, Canettieri G and Montminy MR: Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB. Proc Natl Acad Sci USA. 98:10936–10941. 2001. View Article : Google Scholar : PubMed/NCBI
36	Amorino GP, Hamilton VM, Valerie K, Dent P, Lammering G and Schmidt-Ullrich RK: Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Mol Biol Cell. 13:2233–2244. 2002. View Article : Google Scholar : PubMed/NCBI
37	Matsumoto K, Yamamoto T, Kurachi H, Nishio Y, Takeda T, Homma H, Morishige K, Miyake A and Murata Y: Human chorionic gonadotropin-alpha gene is transcriptionally activated by epidermal growth factor through cAMP response element in trophoblast cells. J Biol Chem. 273:7800–7806. 1998. View Article : Google Scholar : PubMed/NCBI
38	Swarthout JT, Tyson DR, Jefcoat SC Jr and Partridge NC: Induction of transcriptional activity of the cyclic adenosine monophosphate response element binding protein by parathyroid hormone and epidermal growth factor in osteoblastic cells. J Bone Miner Res. 17:1401–1407. 2002. View Article : Google Scholar : PubMed/NCBI